TG THERAPEUTICS, INC. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2021-06-18

Reporting Person: Lonial Sagar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-18	COMMON STOCK	A	20000	—	Acquired	85000	Direct

Footnotes

F1: Reflects a grant of restricted shares which will vest on June 18, 2024.

F2: Includes shares of restricted Common Stock, which vest over various time periods.